The extended offer period for BASF’s voluntary cash offer to shareholders of Pronova BioPharma ASA, Lysaker, Norway, ended on January 18, 2013, 16:30 CET. During the offer period, a total of 293,975,655 Pronova shares have been tendered to BASF. This corresponds to 97.7% of all Pronova shares.